Appeals court upholds CRISPR patents awarded to the Broad Institute
Barring an appeal to the U.S. Supreme Court, which is highly unlikely to accept the case, the long and bitter legal saga is largely over, at least in the U.S.
A federal appeals court on Monday struck another blow against the University of California’s hopes of invalidating key CRISPR patents held by the Broad Institute of MIT and Harvard, ruling unanimously that a U.S. patent board correctly concluded that the Broad’s patents did not “interfere” with those that UC had applied for.
Barring an appeal to the U.S. Supreme Court, which is highly unlikely to accept the case, or a request for the full U.S. Court of Appeals for the Federal Circuit to consider the case, the is largely over, at least in the continues.)
